CTIC logo

CTI BioPharma (CTIC) Net Income

CTIC Annual Net Income

-$92.99 M
+$4.92 M+5.02%

31 December 2022

CTIC Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC Quarterly Net Income

-$13.42 M
+$4.04 M+23.12%

31 March 2023

CTIC Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC TTM Net Income

-$69.24 M
+$23.75 M+25.54%

31 March 2023

CTIC TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CTIC Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.0%+63.9%+41.2%
3 y3 years-132.4%-10.1%-67.3%
5 y5 years-128.7%-233.8%-73.0%

CTIC Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time+569.0%-144.0%+1136.4%

CTI BioPharma Net Income History

DateAnnualQuarterlyTTM
Mar 2023
-
-$13.42 M(-23.1%)
-$69.24 M(-25.5%)
Dec 2022
-$92.99 M(-5.0%)
-$17.46 M(+11.2%)
-$92.99 M(-17.2%)
Sept 2022
-
-$15.71 M(-30.7%)
-$112.32 M(-7.0%)
June 2022
-
-$22.65 M(-39.1%)
-$120.80 M(+2.5%)
Mar 2022
-
-$37.17 M(+1.1%)
-$117.82 M(+20.3%)
Dec 2021
-$97.91 M(+86.7%)
-$36.79 M(+52.1%)
-$97.91 M(+28.6%)
Sept 2021
-
-$24.18 M(+22.9%)
-$76.12 M(+20.4%)
June 2021
-
-$19.68 M(+14.0%)
-$63.21 M(+9.9%)
Mar 2021
-
-$17.27 M(+15.1%)
-$57.53 M(+9.7%)
Dec 2020
-$52.45 M(+31.1%)
-$15.00 M(+33.2%)
-$52.45 M(+14.9%)
Sept 2020
-
-$11.26 M(-19.6%)
-$45.64 M(+2.7%)
June 2020
-
-$14.00 M(+14.9%)
-$44.42 M(+7.3%)
Mar 2020
-
-$12.19 M(+48.8%)
-$41.39 M(+3.4%)
Dec 2019
-$40.02 M(+36.5%)
-$8.19 M(-18.5%)
-$40.02 M(+29.2%)
Sept 2019
-
-$10.05 M(-8.4%)
-$30.99 M(-13.3%)
June 2019
-
-$10.97 M(+1.5%)
-$35.75 M(-1.0%)
Mar 2019
-
-$10.81 M(-1378.3%)
-$36.11 M(+23.2%)
Dec 2018
-$29.32 M(-27.9%)
$846.00 K(-105.7%)
-$29.32 M(-34.0%)
Sept 2018
-
-$14.81 M(+30.6%)
-$44.43 M(+6.8%)
June 2018
-
-$11.34 M(+181.9%)
-$41.60 M(+67.3%)
Mar 2018
-
-$4.02 M(-71.8%)
-$24.86 M(-38.9%)
Dec 2017
-$40.67 M(-21.8%)
-$14.27 M(+19.1%)
-$40.67 M(+24.1%)
Sept 2017
-
-$11.97 M(-321.8%)
-$32.78 M(-34.4%)
June 2017
-
$5.40 M(-127.2%)
-$49.98 M(-33.5%)
Mar 2017
-
-$19.83 M(+211.2%)
-$75.15 M(+44.5%)
Dec 2016
-$52.01 M(-56.4%)
-$6.37 M(-78.2%)
-$52.01 M(-27.0%)
Sept 2016
-
-$29.18 M(+47.6%)
-$71.27 M(-4.6%)
June 2016
-
-$19.77 M(-696.8%)
-$74.68 M(-14.7%)
Mar 2016
-
$3.31 M(-112.9%)
-$87.51 M(-26.7%)
Dec 2015
-$119.42 M(+27.9%)
-$25.64 M(-21.3%)
-$119.42 M(-11.8%)
Sept 2015
-
-$32.59 M(-0.0%)
-$135.35 M(+37.9%)
June 2015
-
-$32.60 M(+14.0%)
-$98.16 M(+5.6%)
Mar 2015
-
-$28.60 M(-31.2%)
-$92.96 M(-0.4%)
Dec 2014
-$93.37 M(+118.4%)
-$41.57 M(-1003.1%)
-$93.37 M(+124.4%)
Sept 2014
-
$4.60 M(-116.8%)
-$41.60 M(-32.6%)
June 2014
-
-$27.40 M(-5.5%)
-$61.75 M(+17.9%)
Mar 2014
-
-$29.00 M(-384.4%)
-$52.36 M(+22.5%)
Dec 2013
-$42.74 M(-57.8%)
$10.20 M(-165.6%)
-$42.74 M(-40.3%)
Sept 2013
-
-$15.54 M(-13.7%)
-$71.54 M(+0.5%)
June 2013
-
-$18.01 M(-7.1%)
-$71.19 M(-31.1%)
Mar 2013
-
-$19.38 M(+4.2%)
-$103.31 M(+1.9%)
Dec 2012
-$101.37 M(+62.6%)
-$18.60 M(+22.5%)
-$101.37 M(+10.5%)
Sept 2012
-
-$15.19 M(-69.7%)
-$91.74 M(-1.6%)
June 2012
-
-$50.14 M(+187.4%)
-$93.21 M(+55.2%)
Mar 2012
-
-$17.45 M(+94.6%)
-$60.07 M(-3.7%)
Dec 2011
-$62.36 M(-24.5%)
-$8.97 M(-46.2%)
-$62.36 M(-14.7%)
Sept 2011
-
-$16.66 M(-2.0%)
-$73.11 M(+6.0%)
June 2011
-
-$17.00 M(-13.9%)
-$68.97 M(-8.6%)
Mar 2011
-
-$19.73 M(+0.1%)
-$75.46 M(-8.7%)
Dec 2010
-$82.64 M(-13.4%)
-$19.72 M(+57.5%)
-$82.64 M(-8.5%)
Sept 2010
-
-$12.52 M(-46.7%)
-$90.30 M(-19.9%)
June 2010
-
-$23.48 M(-12.8%)
-$112.80 M(+5.1%)
Mar 2010
-
-$26.92 M(-1.7%)
-$107.35 M(+12.5%)
DateAnnualQuarterlyTTM
Dec 2009
-$95.39 M(-47.0%)
-$27.38 M(-21.8%)
-$95.39 M(-10.2%)
Sept 2009
-
-$35.02 M(+94.3%)
-$106.27 M(-9.0%)
June 2009
-
-$18.03 M(+20.4%)
-$116.84 M(-25.5%)
Mar 2009
-
-$14.97 M(-60.9%)
-$156.83 M(-12.9%)
Dec 2008
-$180.03 M(+30.4%)
-$38.25 M(-16.1%)
-$180.03 M(+0.4%)
Sept 2008
-
-$45.59 M(-21.4%)
-$179.34 M(-1.6%)
June 2008
-
-$58.02 M(+52.0%)
-$182.22 M(+21.4%)
Mar 2008
-
-$38.16 M(+1.6%)
-$150.16 M(+8.7%)
Dec 2007
-$138.11 M(+1.7%)
-$37.56 M(-22.5%)
-$138.11 M(+3.1%)
Sept 2007
-
-$48.47 M(+86.7%)
-$133.97 M(+17.8%)
June 2007
-
-$25.96 M(-0.6%)
-$113.69 M(+5.1%)
Mar 2007
-
-$26.11 M(-21.9%)
-$108.20 M(-19.3%)
Dec 2006
-$135.82 M(+32.5%)
-$33.42 M(+18.5%)
-$134.00 M(+12.3%)
Sept 2006
-
-$28.20 M(+37.7%)
-$119.28 M(+19.8%)
June 2006
-
-$20.47 M(-60.6%)
-$99.59 M(-13.6%)
Mar 2006
-
-$51.92 M(+177.7%)
-$115.29 M(+12.5%)
Dec 2005
-$102.50 M(-59.4%)
-$18.69 M(+119.8%)
-$102.50 M(-19.5%)
Sept 2005
-
-$8.50 M(-76.5%)
-$127.35 M(-17.2%)
June 2005
-
-$36.17 M(-7.6%)
-$153.75 M(-0.8%)
Mar 2005
-
-$39.13 M(-10.1%)
-$155.03 M(-38.6%)
Dec 2004
-$252.30 M(+94.0%)
-$43.54 M(+24.7%)
-$252.30 M(+2.8%)
Sept 2004
-
-$34.91 M(-6.8%)
-$245.43 M(+1.1%)
June 2004
-
-$37.46 M(-72.5%)
-$242.64 M(+2.8%)
Mar 2004
-
-$136.40 M(+272.0%)
-$235.96 M(+81.5%)
Dec 2003
-$130.03 M(+160.6%)
-$36.67 M(+14.2%)
-$130.03 M(+107.0%)
Sept 2003
-
-$32.12 M(+4.4%)
-$62.83 M(+2.8%)
June 2003
-
-$30.78 M(+1.0%)
-$61.10 M(+7.5%)
Mar 2003
-
-$30.47 M(-199.8%)
-$56.81 M(+13.8%)
Dec 2002
-$49.90 M(-37.8%)
$30.54 M(-200.5%)
-$49.90 M(-55.4%)
Sept 2002
-
-$30.39 M(+14.7%)
-$111.93 M(+8.8%)
June 2002
-
-$26.49 M(+12.4%)
-$102.88 M(+11.5%)
Mar 2002
-
-$23.56 M(-25.2%)
-$92.25 M(+14.9%)
Dec 2001
-$80.27 M(+54.6%)
-$31.49 M(+47.5%)
-$80.27 M(+25.8%)
Sept 2001
-
-$21.34 M(+34.5%)
-$63.83 M(+13.0%)
June 2001
-
-$15.87 M(+37.0%)
-$56.47 M(+8.1%)
Mar 2001
-
-$11.58 M(-23.0%)
-$52.25 M(+1.0%)
Dec 2000
-$51.93 M(+43.1%)
-$15.05 M(+7.6%)
-$51.74 M(+14.7%)
Sept 2000
-
-$13.98 M(+20.1%)
-$45.09 M(+9.7%)
June 2000
-
-$11.64 M(+5.2%)
-$41.11 M(+4.4%)
Mar 2000
-
-$11.07 M(+31.8%)
-$39.37 M(+8.2%)
Dec 1999
-$36.30 M(+45.2%)
-$8.40 M(-16.0%)
-$36.40 M(+1.1%)
Sept 1999
-
-$10.00 M(+1.0%)
-$36.00 M(+13.9%)
June 1999
-
-$9.90 M(+22.2%)
-$31.60 M(+17.5%)
Mar 1999
-
-$8.10 M(+1.3%)
-$26.90 M(+7.6%)
Dec 1998
-$25.00 M(+8.7%)
-$8.00 M(+42.9%)
-$25.00 M(-0.8%)
Sept 1998
-
-$5.60 M(+7.7%)
-$25.20 M(+5.4%)
June 1998
-
-$5.20 M(-16.1%)
-$23.90 M(+1.3%)
Mar 1998
-
-$6.20 M(-24.4%)
-$23.60 M(+2.6%)
Dec 1997
-$23.00 M(+65.5%)
-$8.20 M(+90.7%)
-$23.00 M(+55.4%)
Sept 1997
-
-$4.30 M(-12.2%)
-$14.80 M(+41.0%)
June 1997
-
-$4.90 M(-12.5%)
-$10.50 M(+87.5%)
Mar 1997
-
-$5.60 M
-$5.60 M
Dec 1996
-$13.90 M
-
-

FAQ

  • What is CTI BioPharma annual net profit?
  • What is the all time high annual net income for CTI BioPharma?
  • What is CTI BioPharma annual net income year-on-year change?
  • What is CTI BioPharma quarterly net profit?
  • What is the all time high quarterly net income for CTI BioPharma?
  • What is CTI BioPharma quarterly net income year-on-year change?
  • What is CTI BioPharma TTM net profit?
  • What is the all time high TTM net income for CTI BioPharma?
  • What is CTI BioPharma TTM net income year-on-year change?

What is CTI BioPharma annual net profit?

The current annual net income of CTIC is -$92.99 M

What is the all time high annual net income for CTI BioPharma?

CTI BioPharma all-time high annual net profit is -$13.90 M

What is CTI BioPharma annual net income year-on-year change?

Over the past year, CTIC annual net profit has changed by +$4.92 M (+5.02%)

What is CTI BioPharma quarterly net profit?

The current quarterly net income of CTIC is -$13.42 M

What is the all time high quarterly net income for CTI BioPharma?

CTI BioPharma all-time high quarterly net profit is $30.54 M

What is CTI BioPharma quarterly net income year-on-year change?

Over the past year, CTIC quarterly net profit has changed by +$23.75 M (+63.90%)

What is CTI BioPharma TTM net profit?

The current TTM net income of CTIC is -$69.24 M

What is the all time high TTM net income for CTI BioPharma?

CTI BioPharma all-time high TTM net profit is -$5.60 M

What is CTI BioPharma TTM net income year-on-year change?

Over the past year, CTIC TTM net profit has changed by +$48.58 M (+41.23%)